FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * Ho Peter Tai-Ching 2. Issuer Name and Ticker or Trading Symbol Aravive, Inc. [ ARAV ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)__X__ Director                    _____ 10% Owner
_____ Officer (give title below)    _____ Other (specify below)
(Last)         (First)         (Middle)
C/O ARAVIVE, INC., RIVER OAKS TOWER,, 3730 KIRBY DRIVE, SUITE 1200
3. Date of Earliest Transaction (MM/DD/YYYY)
7/1/2021
(Street)
HOUSTON, TX 77098
(City)       (State)       (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)
 
6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options  $5.80  7/1/2021    A     15435 (1)     7/1/2021  6/30/2031  Common Stock  15435  $0  15435  D   
Stock Options  $5.80  7/1/2021    A     5245 (2)     7/1/2021  6/30/2031  Common Stock  5245  $0  5245  D   

Explanation of Responses:
(1)  Consists of options to purchase 15,435 shares of the Corporation's common stock, with immediate vesting as to 858 shares and 14,577 shares vesting pro rata over 34 months commencing on the one-month anniversary of the date of grant.
(2)  Consists of options to purchase 5,245 shares of the Corporation's common stock, with immediate vesting as to 2,623 shares and 2,622 shares vesting on a monthly basis over two (2) months commencing on the one-month anniversary of the grant date with full vesting, if not fully vested at such time, on the date of the Corporation's next annual meeting of stockholders

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Ho Peter Tai-Ching
C/O ARAVIVE, INC., RIVER OAKS TOWER,
3730 KIRBY DRIVE, SUITE 1200
HOUSTON, TX 77098
X



Signatures
/s/ Abel Svitavsky, Attorney-in-fact 7/2/2021
**Signature of Reporting Person Date
Aravive (NASDAQ:ARAV)
Historical Stock Chart
From Oct 2021 to Nov 2021 Click Here for more Aravive Charts.
Aravive (NASDAQ:ARAV)
Historical Stock Chart
From Nov 2020 to Nov 2021 Click Here for more Aravive Charts.